Released Sep 14, 2016, after the close
10-Q filed Sep 14, 2016, 45 days after period end · 0001654954-16-002192
Q3 2016 · 10-Q
Revenue—
Net Income-$130.47K-$130.47K N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.01-$0.01 N/M vs Q3 2015N/M vs Q2 2016
Gross Profit$1,425,893−30.3%
Operating Income-$120,786N/M
Operating Cash Flow$44,121N/M
Free Cash Flowderived-$420,465N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$130.47K | $453.97K | $597.06K | $1.25M |
| EPS Diluted | -$0.01 | $0.02 | $0.03 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR